Dr. Salk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1660 S Columbian Way
# S-111ONC
Seattle, WA 98108Phone+1 206-277-4757Fax+1 206-764-2119
Education & Training
University of WashingtonResidency, Internal Medicine, 2012 - 2015- University of Washington School of MedicineClass of 2012
Certifications & Licensure
WA State Medical License 2012 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 65 citationsUltra-Sensitive TP53 Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue over a Century of Human Lifespan.Jesse J. Salk, Kaitlyn Loubet-Senear, Elisabeth Maritschnegg, Charles C. Valentine, Lindsey N. Williams
Cell Reports. 2019-07-02 - 690 citationsDetection of ultra-rare mutations by next-generation sequencingMichael W. Schmitt, Scott R. Kennedy, Jesse J. Salk, Edward J. Fox, Joseph Hiatt
Proceedings of the National Academy of Sciences of the United States of America. 2012-09-04 - 298 citationsDetecting ultralow-frequency mutations by Duplex SequencingScott R. Kennedy, Michael W. Schmitt, Edward J. Fox, Brendan F. Kohrn, Jesse J. Salk
Nature Protocols. 2014-11-01
Abstracts/Posters
- Redefining Gold Standard: Ultra-Sensitive Characterization of Commercial DNA Standards with Duplex SequencingJesse J. Salk, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Characterization of Clonal Dynamics after Hematopoietic Cell Transplantation Using Ultra-Sensitive Duplex SequencingJesse J. Salk, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Ultra-Accurate Assessment of Pretreatment ABL1 Kinase Domain (KD) Mutations in Patients (pts) with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic...Jesse J. Salk, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
Cancer’s Cartographer Redraws Tumor TreatmentSeptember 30th, 2021- Seattle Startup TwinStrand Raises $50M to Expand Tech That Identifies Rare Genetic MutantsMay 6th, 2021
- TwinStrand Biosciences Appoints Dr. Gary Gilliland to Board of DirectorsJanuary 6th, 2021
- Join now to see all
Grant Support
- Somatic Mutations In Human AgingNational Institute On Aging2008–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
